L Galván
Biographic Data
| ID | 7668113 |
|---|---|
| NAME | L Galván |
| GIVEN NAMES | L |
| FAMILY NAME | Galván |
| SIGNATURE | GALVÁN L |
| AFFILIATIONS | Servei de Salut de les Illes Balears |
| ORCID | 0000-0003-1767-0580 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
An increase in the prevalence of PPI dispensation was observed over 14 years of follow-up. The prevalence of dispensation was especially high for the population older than 65 years, despite the risk of cognitive decline and falls. Comprehensive actions are required to to increase rational prescribing of PPIs, especially in high-risk populations
Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015
The dispensing prevalence of BZDs and Z-drugs was high, although a small reduction was observed during this time period. The dispensing prevalence was especially high in the population over 65, despite the risk of cognitive decline and falls. Integral actions are required to lower the BZD prescription rate
No prominent works on this page.
Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015
The dispensing prevalence of BZDs and Z-drugs was high, although a small reduction was observed during this time period. The dispensing prevalence was especially high in the population over 65, despite the risk of cognitive decline and falls. Integral actions are required to lower the BZD prescription rate
Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
An increase in the prevalence of PPI dispensation was observed over 14 years of follow-up. The prevalence of dispensation was especially high for the population older than 65 years, despite the risk of cognitive decline and falls. Comprehensive actions are required to to increase rational prescribing of PPIs, especially in high-risk populations
Biostatistics (2 works) · Defined daily dose (2 works) · Demography (2 works) · Demography (2 works) · Environmental health (2 works) · Epidemiology (2 works) · Internal Medicine (2 works) · Medical prescription (2 works) · Medicine (2 works) · Pharmacology (2 works)